247 related articles for article (PubMed ID: 34768771)
21. Rates of cerebral atrophy differ in different degenerative pathologies.
Whitwell JL; Jack CR; Parisi JE; Knopman DS; Boeve BF; Petersen RC; Ferman TJ; Dickson DW; Josephs KA
Brain; 2007 Apr; 130(Pt 4):1148-58. PubMed ID: 17347250
[TBL] [Abstract][Full Text] [Related]
22. Smelling the Dark Proteome: Functional Characterization of PITH Domain-Containing Protein 1 (C1orf128) in Olfactory Metabolism.
Lachén-Montes M; Mendizuri N; Ausín K; Pérez-Mediavilla A; Azkargorta M; Iloro I; Elortza F; Kondo H; Ohigashi I; Ferrer I; de la Torre R; Robledo P; Fernández-Irigoyen J; Santamaría E
J Proteome Res; 2020 Dec; 19(12):4826-4843. PubMed ID: 33185454
[TBL] [Abstract][Full Text] [Related]
23. Systematic review and meta-analysis of human transcriptomics reveals neuroinflammation, deficient energy metabolism, and proteostasis failure across neurodegeneration.
Noori A; Mezlini AM; Hyman BT; Serrano-Pozo A; Das S
Neurobiol Dis; 2021 Feb; 149():105225. PubMed ID: 33347974
[TBL] [Abstract][Full Text] [Related]
24. Microglia is associated with p-Tau aggregates in the olfactory bulb of patients with neurodegenerative diseases.
Carmona-Abellan M; Martinez-Valbuena I; Marcilla I; DiCaudo C; Gil I; Nuñez J; Luquin MR
Neurol Sci; 2021 Apr; 42(4):1473-1482. PubMed ID: 32816165
[TBL] [Abstract][Full Text] [Related]
25. Olfactory bulb involvement in neurodegenerative diseases.
Attems J; Walker L; Jellinger KA
Acta Neuropathol; 2014 Apr; 127(4):459-75. PubMed ID: 24554308
[TBL] [Abstract][Full Text] [Related]
26. Olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders.
Beach TG; White CL; Hladik CL; Sabbagh MN; Connor DJ; Shill HA; Sue LI; Sasse J; Bachalakuri J; Henry-Watson J; Akiyama H; Adler CH;
Acta Neuropathol; 2009 Feb; 117(2):169-74. PubMed ID: 18982334
[TBL] [Abstract][Full Text] [Related]
27. Quantitative proteomics reveals olfactory input-dependent alterations in the mouse olfactory bulb proteome.
Zeng HL; Rao X; Zhang LK; Zhao X; Zhang WP; Wang J; Xu F; Guo L
J Proteomics; 2014 Sep; 109():125-42. PubMed ID: 24998433
[TBL] [Abstract][Full Text] [Related]
28. Intact protein analysis of ubiquitin in cerebrospinal fluid by multiple reaction monitoring reveals differences in Alzheimer's disease and frontotemporal lobar degeneration.
Oeckl P; Steinacker P; von Arnim CA; Straub S; Nagl M; Feneberg E; Weishaupt JH; Ludolph AC; Otto M
J Proteome Res; 2014 Nov; 13(11):4518-25. PubMed ID: 25091646
[TBL] [Abstract][Full Text] [Related]
29. Selective Genetic Overlap Between Amyotrophic Lateral Sclerosis and Diseases of the Frontotemporal Dementia Spectrum.
Karch CM; Wen N; Fan CC; Yokoyama JS; Kouri N; Ross OA; Höglinger G; Müller U; Ferrari R; Hardy J; Schellenberg GD; Sleiman PM; Momeni P; Hess CP; Miller BL; Sharma M; Van Deerlin V; Smeland OB; Andreassen OA; Dale AM; Desikan RS;
JAMA Neurol; 2018 Jul; 75(7):860-875. PubMed ID: 29630712
[TBL] [Abstract][Full Text] [Related]
30. Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases.
Sasaki N; Fukatsu R; Tsuzuki K; Hayashi Y; Yoshida T; Fujii N; Koike T; Wakayama I; Yanagihara R; Garruto R; Amano N; Makita Z
Am J Pathol; 1998 Oct; 153(4):1149-55. PubMed ID: 9777946
[TBL] [Abstract][Full Text] [Related]
31. Casein kinase 1 delta is associated with pathological accumulation of tau in several neurodegenerative diseases.
Schwab C; DeMaggio AJ; Ghoshal N; Binder LI; Kuret J; McGeer PL
Neurobiol Aging; 2000; 21(4):503-10. PubMed ID: 10924763
[TBL] [Abstract][Full Text] [Related]
32. The Role of Bioenergetics in Neurodegeneration.
Strope TA; Birky CJ; Wilkins HM
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012480
[TBL] [Abstract][Full Text] [Related]
33. RNA sequencing of olfactory bulb in Parkinson's disease reveals gene alterations associated with olfactory dysfunction.
Tremblay C; Aslam S; Walker JE; Lorenzini I; Intorcia AJ; Arce RA; Choudhury P; Adler CH; Shill HA; Driver-Dunckley E; Mehta S; Piras IS; Belden CM; Atri A; Beach TG; Serrano GE
Neurobiol Dis; 2024 Jun; 196():106514. PubMed ID: 38663633
[TBL] [Abstract][Full Text] [Related]
34. Alpha-synuclein pathology in the olfactory pathways of dementia patients.
Hubbard PS; Esiri MM; Reading M; McShane R; Nagy Z
J Anat; 2007 Jul; 211(1):117-24. PubMed ID: 17553102
[TBL] [Abstract][Full Text] [Related]
35. The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases.
Rey NL; Wesson DW; Brundin P
Neurobiol Dis; 2018 Jan; 109(Pt B):226-248. PubMed ID: 28011307
[TBL] [Abstract][Full Text] [Related]
36. Proteomic atlas of the human olfactory bulb.
Fernández-Irigoyen J; Corrales FJ; Santamaría E
J Proteomics; 2012 Jul; 75(13):4005-16. PubMed ID: 22609191
[TBL] [Abstract][Full Text] [Related]
37. Prodromal Parkinson's disease and the catecholaldehyde hypothesis: Insight from olfactory bulb organotypic cultures.
Bagnoli E; Trotier A; McMahon J; Quinlan LR; Biggs M; Pandit A; FitzGerald U
FASEB J; 2023 Dec; 37(12):e23272. PubMed ID: 37997495
[TBL] [Abstract][Full Text] [Related]
38. Expression of intercellular adhesion molecule (ICAM)-1 by a subset of astrocytes in Alzheimer disease and some other degenerative neurological disorders.
Akiyama H; Kawamata T; Yamada T; Tooyama I; Ishii T; McGeer PL
Acta Neuropathol; 1993; 85(6):628-34. PubMed ID: 8337942
[TBL] [Abstract][Full Text] [Related]
39. Differentially Expressed miRNAs in Age-Related Neurodegenerative Diseases: A Meta-Analysis.
Noronha O; Mesarosovo L; Anink JJ; Iyer A; Aronica E; Mills JD
Genes (Basel); 2022 Jun; 13(6):. PubMed ID: 35741796
[TBL] [Abstract][Full Text] [Related]
40. Transcriptomic Insights into the Response of the Olfactory Bulb to Selenium Treatment in a Mouse Model of Alzheimer's Disease.
Zheng R; Zhang ZH; Zhao YX; Chen C; Jia SZ; Cao XC; Shen LM; Ni JZ; Song GL
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31248178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
